Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease.

Frontiers in medicine·2025
Same author

A case of acquired thrombotic thrombocytopenic purpura following near-drowning.

Clinical nephrology. Case studies·2024
Same author

Syndrome of inappropriate antidiuretic hormone secretion associated with prolonged keterolac use.

Clinical nephrology. Case studies·2017
Same author

Wnt signaling and podocyte dysfunction in diabetic nephropathy.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2017
Same author

Synthetic cannabinoids and acute kidney injury.

Proceedings (Baylor University. Medical Center)·2015
Same author

Potential aetiologies and prognostic implications of worsening renal function in acute decompensated heart failure.

Acta cardiologica·2015

Related Experiment Videos

Lipids and diabetic nephropathy.

Rey F Rosario, Sharma Prabhakar

    Current Diabetes Reports
    |November 23, 2006
    PubMed
    Summary

    High lipids (hyperlipidemia) are a key factor in diabetic kidney disease progression. Research explores how hyperlipidemia damages kidneys and how treating it can help manage diabetic renal disease.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Cardiovascular Medicine

    Background:

    • Diabetic nephropathy is a leading cause of kidney failure.
    • Hyperlipidemia is increasingly recognized as a significant, independent risk factor for diabetic kidney disease progression.
    • Understanding the role of lipids in renal injury is crucial for effective diabetes management.

    Purpose of the Study:

    • To review experimental evidence linking hyperlipidemia to diabetic nephropathy pathogenesis.
    • To explore potential mechanisms of renal injury mediated by hyperlipidemia.
    • To analyze clinical studies on lipid-lowering therapies and their impact on diabetic renal disease progression.

    Main Methods:

    • Review of experimental studies on hyperlipidemia and kidney damage.

    Related Experiment Videos

  • Analysis of proposed molecular and cellular mechanisms of renal injury.
  • Evaluation of clinical trials investigating lipid-modifying treatments in diabetic patients.

    • Main Results:

    • Experimental data strongly implicates hyperlipidemia in the development and progression of diabetic nephropathy.
    • Several mechanisms, including oxidative stress and inflammation, are proposed for hyperlipidemic renal injury.
    • Clinical studies suggest that managing hyperlipidemia can positively influence the course of diabetic renal disease.

    Conclusions:

    • Hyperlipidemia is a critical, independent determinant of diabetic nephropathy progression.
    • Targeting hyperlipidemia presents a viable therapeutic strategy to mitigate renal damage in diabetic patients.
    • Further research into lipid-lowering interventions is warranted to optimize kidney protection in diabetes.